new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Glaxosmithkline Intellectual Property Development Limited patents

Recent patent applications related to Glaxosmithkline Intellectual Property Development Limited. Glaxosmithkline Intellectual Property Development Limited is listed as an Agent/Assignee. Note: Glaxosmithkline Intellectual Property Development Limited may have other listings under different names/spellings. We're not affiliated with Glaxosmithkline Intellectual Property Development Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glaxosmithkline Intellectual Property Development Limited-related inventors




Date Glaxosmithkline Intellectual Property Development Limited patents (updated weekly) - BOOKMARK this page
05/11/17Amino-quinolines as kinase inhibitors
05/04/17Retosiban for the treatment of pre-term labour
05/04/17Novel compounds
04/13/17Novel compounds
01/26/17Compounds
01/19/17Compounds
01/12/17Heterocyclic amides as kinase inhibitors
12/22/16Benzothiophene derivatives as estrogen receptor inhibitors
12/15/16Icos binding proteins
12/08/16Microbiological process
11/24/16Topical pharmaceutical compositions
11/03/163-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors
11/03/16Nrf2 regulators
10/27/16Compound (s) and (r)-n-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropyrido[3,4-d]pyrimidin-3(4h)-yl)butanamide and use
09/29/16Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
09/22/16Novel compounds as rearranged during transfection (ret) inhibitors
09/15/16P13k inhibitor for treatment of respiratory disease
09/15/16Tslp binding proteins
09/08/16Pi3k inhibitor for treatment of respiratory disease
08/04/16Compounds for affinity chromatography and for extending the half-life of a therapeutic agent
07/28/16Novel soluble guanylate cyclase activators and their use
07/28/16Icos binding proteins
07/21/16Prodrugs of amino quinazoline kinase inhibitor
06/16/16Topical compositions for treatment of excessive sweating and methods of use thereof
06/02/16Enzyme and receptor modulation
05/19/16Novel compounds
05/19/16Hdac inhibitors
04/21/16Therapeutic peptides
03/24/16Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
03/17/16A prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
03/17/16Electronically predicting corrective options based on a sensed physiological characteristic
03/10/16Combinations
03/03/16Amino-quinolines as kinase inhibitors
03/03/16Quinolyl amines as kinase inhibitors
02/25/16Anti-serum albumin binding variants
01/21/16Anti-lag-3 binding proteins
01/07/16Pyridine derivatives as rearranged during transfection (ret) kinase inhibitors
12/24/15Tnf-alpha antigen-binding proteins
12/17/15Quinazolines as kinase inhibitors
12/17/152,3-dihydroimidazol[1,2-c]pyrimidin-5(1-h)-one based ipoprotein-associated phospholipase a2 (lp-pla2) inhibitors
12/10/15Heterocyclic amides as kinase inhibitors
12/03/15Bicyclic pyrimidone compounds as inhibitors of lp-pla2
11/12/15Compounds
06/25/15Alpha-galactosidase a and 1-deoxygalactonojirimycin co-formulation
04/09/15Compounds as rearranged during transfection (ret) inhibitors
04/02/15Amino-quinolines as kinase inhibitors
03/26/15Aggregate particles
03/19/15Therapeutic uses
02/12/15Prodrugs of amino quinazoline kinase inhibitor
02/05/15Topical compositions for treatment of excessive sweating and methods of use thereof
09/25/14Antigen binding proteins
09/18/14Novel compounds as rearranged during transfection (ret) inhibitors
09/11/14Novel polymorphs and salts
09/11/14Quinolyl amines as kinase inhibitors
07/31/14Compounds
07/10/14Method of drug repositioning
03/20/14Novel compounds
11/28/13Method of administration and treatment
08/08/13Anti-serum albumin binding variants
07/04/13Drug delivery devices
07/04/13Fatty acid synthase inhibitors
06/27/13Novel use
06/27/13Novel polymorphs and salts







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Intellectual Property Development Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Intellectual Property Development Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';